Clara Rodríguez Fernández, Author at Labiotech.eu

About

Traveler, musician, food enthusiast and book worm. Always on the hunt for interesting facts and news.

Articles by Clara Rodríguez Fernández

More News! 11 Oct 2019

RNA Therapy Improves Vision in Untreatable Genetic Blindness

A phase I/II trial run by the Dutch company ProQR has found that its RNA therapy could significantly improve the vision of people with Leber’s congenital amaurosis, a rare genetic disease for which there is no treatment. The RNA drug, called sepofarsen, is designed to treat people with a specific mutation in a gene […]

October 11, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Oct 2019

Update: BioNTech Files for €141M Nasdaq IPO

BioNTech’s Nasdaq IPO has raised €141M ($155M), a lower sum than it initially anticipated. The timing of the IPO means it has likely been impacted by adverse market conditions, which are due to factors such as global manufacturing slowdowns and escalations in US and Chinese trade disputes. This same market volatility led several companies such […]

October 10, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Interview 30 Sep 2019

Taking Your Product Forward Against All Odds

Having to let go of your flagship product after years of development is not easy. Nor is fundraising for another product after a major partner backs out — a challenge that Angela Hildreth had to confront when she joined the British company Futura Medical as Finance Director last year. Angela Hildreth had never worked in […]

September 30, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

Themis Biosciences fundraising chikungunya vaccine

News and Trends 18 Sep 2019

Themis Raises €40M for First Phase III Trial of a Chikungunya Vaccine

Vienna-based Themis Biosciences has raised €40M in a Series D round to fund a phase III trial that could lead to the approval of the world’s first vaccine for chikungunya infection. The round, one of the largest seen in Austrian biotech so far, was co-led by two new investors, Farallon Capital and Hadean Ventures. […]

September 18, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

Switzerland Hôpitaux Universitaires Genève HUG

News and Trends 11 Sep 2019

IBM’s Watson for Genomics Launches in First European Hospital

The Hôpitaux Universitaires Genève in Switzerland will be the first European university hospital to implement IBM’s artificial intelligence to help doctors select treatments for complex cancer cases. “Artificial intelligence could empower our clinicians to increase the speed of diagnosing their patients,” said Rodolphe Meyer, who is responsible for the IT department of […]

September 11, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 9 Sep 2019

Top 10 Food Tech Companies in Europe in 2019

Food tech companies in Europe are striving to change how food is made to bring us closer to a more sustainable future. Here are some of the top companies you’ll find in this field. Food doesn’t just keep us alive, it is part of our culture and our daily routine, and it plays a key […]

September 9, 2019 - 5 minutesmins - By Clara Rodríguez Fernández

News and Trends 5 Sep 2019

Orchard’s Gene Therapy Improves Children’s Motor Ability

Orchard Therapeutics’ gene therapy for metachromatic leukodystrophy (MLD) resulted in motor ability improvements more than six times over the target endpoint, according to data released at a recent symposium. “Metachromatic leukodystrophy is a rare disease that affects the brain,” explained Mark Rothera, CEO of Orchard Therapeutics. “Kids born with MLD lose motor function very fast […]

September 5, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

DIY diabetes community artificial pancreas

In Depth 2 Sep 2019

How the DIY Diabetes Community Made the Artificial Pancreas Possible

Six years ago, his three-year-old daughter was diagnosed with type 1 diabetes. This led Milos Kozak, a software developer from Prague, to join the DIY diabetes community. “After the diagnosis, I started to look for some solutions because I was really disappointed by the technology available on the market for diabetes,” Kozak told me. That’s […]

September 2, 2019 - 8 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 26 Aug 2019

15 Bioart Exhibitions to Check Out This Fall

The beauty and complexity of biology makes it a fascinating subject for artists to explore. Here are 15 bioart exhibitions to check out that bask in the frontier of art and science. Science and art are often presented as opposites. However, that couldn’t be further from the truth. Creativity is essential for science to progress. […]

August 26, 2019 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 22 Aug 2019

Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III

An experimental HIV therapy being developed by GSK spinoff ViiV Healthcare in partnership with Janssen has proven it is as effective when given every two months as when given once a month. “For the first time since the AIDS epidemic started more than 30 years ago, our study has demonstrated that it is possible to […]

August 22, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 22 Aug 2019

French Biotech Withdraws US Application for its Living Biocide

The US Environment Protection Agency (EPA) has stated it cannot grant registration to a biocide developed by Lyon-based company Amoéba for water treatment in cooling towers. Amoéba’s shares on Euronext Paris went down by 30% on Tuesday following the announcement. The biocide treatment consists of a live strain of amoeba called Willaertia magna C2c Maky. This […]

August 22, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 22 Aug 2019

Austrian Vaccine Developer Signs Deal with MSD in ‘Blockbuster Indication’

Vienna-based Themis Bioscience will develop vaccine candidates against an undisclosed disease target in partnership with big pharma Merck Sharp & Dohme. As part of the agreement, MSD will provide research funding and make an equity investment in Themis Bioscience. In addition, Themis will be eligible to receive up to €200M in milestones, in addition to […]

August 22, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Clara Rodríguez Fernández

About

Articles by Clara Rodríguez Fernández

RNA Therapy Improves Vision in Untreatable Genetic Blindness

Update: BioNTech Files for €141M Nasdaq IPO

Taking Your Product Forward Against All Odds

Themis Raises €40M for First Phase III Trial of a Chikungunya Vaccine

IBM’s Watson for Genomics Launches in First European Hospital

Top 10 Food Tech Companies in Europe in 2019

Orchard’s Gene Therapy Improves Children’s Motor Ability

How the DIY Diabetes Community Made the Artificial Pancreas Possible

15 Bioart Exhibitions to Check Out This Fall

Two-Drug HIV Therapy Given Every 2 Months Proves Effective in Phase III

French Biotech Withdraws US Application for its Living Biocide

Austrian Vaccine Developer Signs Deal with MSD in ‘Blockbuster Indication’

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Clara Rodríguez Fernández

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!